Counter-terrorism symposium held at NJI... ( The public is invited to a counter-t...)

Navigation Links

Biology News Medicine News Biology Products Medicine Products Biology Definition Medicine Definition Biology Technology Medicine Technology Biology Dictionary Medicine Dictionary

HOME >> BIOLOGY >> NEWS

Counter-terrorism symposium held at NJIT tomorrow

Date:10/17/2008

The public is invited to a counter-terrorism symposium tomorrow at NJIT from 8:30 a.m. - 4 p.m. The forum will focus on ways to secure schools, health and transportation facilities, protect customs, borders and port security, strengthen emergency response times and more. Presenters will include NJ State Police, Customs and Border Protection, New Jersey Office of Homeland Security and Preparedness, U.S. Coast Guard and NJ Department of Public Safety. Sponsors include NJ Chapter of the Marine Corps Reserve Association, NY Shipping Association and PhibroChem Ltd. http://www.phibrochem.com/ Ridgefield Park.

Attorney and West Point graduate Tim Connors, a lieutenant colonel in the US Army Reserves, will be the key note speaker. Connors will draw upon anecdotal experiences from his experiences in Afghanistan coupled with his 20-plus years of work in the areas of national defense, counter terrorism, and homeland security.

'/>"/>

Contact: Sheryl Weinstein
sheryl.m.weinstein@njit.edu
973-596-3436
New Jersey Institute of Technology
Source:Eurekalert

0

GOOD

Page: 1
Related biology news :

1. AVS 55th International Symposium & Exhibition, Oct. 19-24
2. Penn presents inaugural symposium on applied mathematics and computational science
3. Ansary Symposium on Stem Cell Research at Weill Cornell Medical College
4. Media invitation: 20th EORTC-NCI-ACR Symposium on Molecular Targets and Cancer Therapeutics
5. 31st Annual San Antonio Breast Cancer Symposium
6. Southern Sierra Science Symposium planned for Visalia
7. The good, the bad and the smelly: USGS at the 2008 Coral Reef Symposium
8. First-ever symposium brings together military and civilian medical experts
9. York symposium puts focus on chemical weather
10. At Boston symposium, NARSAD researchers report on genes and family traits
11. Decade of the Mind symposium in Iowa to emphasize need for $4 billion in federal support

Post Your Comments:

Breaking Biology News(10 mins):UCLA researchers engineer bacteria to turn carbon dioxide into liquid fuel 2 Princeton scientists find way to catalog all that goes wrong in a cancer cell 2 Berkeley Lab researchers participate in Homeland Security study of subway airflow 2 Lockheed Martin Expands Health IT Business with 24170 Million in New Health 26amp 3B Human Services Contract Awards 60095 1 Lockheed Martin Expands Health IT Business with 24170 Million in New Health 26amp 3B Human Services Contract Awards 60095 2 Rcadia Medical Imaging Wins 2009 AuntMinnie com Best New Radiology Vendor Award 5701 1 Rcadia Medical Imaging Wins 2009 AuntMinnie com Best New Radiology Vendor Award 5701 2 Rcadia Medical Imaging Wins 2009 AuntMinnie com Best New Radiology Vendor Award 5701 3 New Data Show CIMZIA 28R 29 28certolizumab pegol 29 Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients 5696 1 New Data Show CIMZIA 28R 29 28certolizumab pegol 29 Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients 5696 2 New Data Show CIMZIA 28R 29 28certolizumab pegol 29 Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients 5696 3 New Data Show CIMZIA 28R 29 28certolizumab pegol 29 Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients 5696 4 New Data Show CIMZIA 28R 29 28certolizumab pegol 29 Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients 5696 5 New Data Show CIMZIA 28R 29 28certolizumab pegol 29 Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients 5696 6 New Data Show CIMZIA 28R 29 28certolizumab pegol 29 Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients 5696 7 New Data Show CIMZIA 28R 29 28certolizumab pegol 29 Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients 5696 8 New Data Show CIMZIA 28R 29 28certolizumab pegol 29 Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients 5696 9 New Data Show CIMZIA 28R 29 28certolizumab pegol 29 Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients 5696 10

[0] UCLA researchers engineer bacteria to turn carbon dioxide into liquid fuel [0] Princeton scientists find way to catalog all that goes wrong in a cancer cell [0] Berkeley Lab researchers participate in Homeland Security study of subway airflow

Other Biology News:Breast cancer genome shows evolution, instability of cancer 2 Breast cancer genome shows evolution, instability of cancer 3 Researchers create new class of fluorescent dyes to detect reactive oxygen species in vivo 2 Researchers create new class of fluorescent dyes to detect reactive oxygen species in vivo 3 Turning over a new leaf for future energy supplies 2

Breast cancer genome shows evolution, instability of cancer Researchers create new class of fluorescent dyes to detect reactive oxygen species in vivo Turning over a new leaf for future energy supplies

Breaking Biology Technology:Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 2 Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 3 Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 4 Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 5 Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 6 Cumberland Pharmaceuticals Licenses Caldolor(R) (ibuprofen) Injection to DB Pharm Korea for Commercialization in South Korea 2 Cumberland Pharmaceuticals Licenses Caldolor(R) (ibuprofen) Injection to DB Pharm Korea for Commercialization in South Korea 3 Cumberland Pharmaceuticals Licenses Caldolor(R) (ibuprofen) Injection to DB Pharm Korea for Commercialization in South Korea 4 Critical Step Toward Commercialization of Pre-Symptomatic Diagnosis of Ovarian Cancer Achieved by Arrayit Diagnostics 2 Critical Step Toward Commercialization of Pre-Symptomatic Diagnosis of Ovarian Cancer Achieved by Arrayit Diagnostics 3 Critical Step Toward Commercialization of Pre-Symptomatic Diagnosis of Ovarian Cancer Achieved by Arrayit Diagnostics 4 Olympics 2016, World Cup 2014, But First – Adventus Brasil 2009 2 Olympics 2016, World Cup 2014, But First – Adventus Brasil 2009 3 Olympics 2016, World Cup 2014, But First – Adventus Brasil 2009 4

[0] Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain [0] Cumberland Pharmaceuticals Licenses Caldolor(R) (ibuprofen) Injection to DB Pharm Korea for Commercialization in South Korea [0] Critical Step Toward Commercialization of Pre-Symptomatic Diagnosis of Ovarian Cancer Achieved by Arrayit Diagnostics [0] Olympics 2016, World Cup 2014, But First – Adventus Brasil 2009

Other Biology Technology:Shire's New Product Portfolio Delivers Strong Quarterly Performance 2 Shire's New Product Portfolio Delivers Strong Quarterly Performance 3 Shire's New Product Portfolio Delivers Strong Quarterly Performance 4 Shire's New Product Portfolio Delivers Strong Quarterly Performance 5 Shire's New Product Portfolio Delivers Strong Quarterly Performance 6 Shire's New Product Portfolio Delivers Strong Quarterly Performance 7 Shire's New Product Portfolio Delivers Strong Quarterly Performance 8 Shire's New Product Portfolio Delivers Strong Quarterly Performance 9 Shire's New Product Portfolio Delivers Strong Quarterly Performance 10 Shire's New Product Portfolio Delivers Strong Quarterly Performance 11 Shire's New Product Portfolio Delivers Strong Quarterly Performance 12 Shire's New Product Portfolio Delivers Strong Quarterly Performance 13 Shire's New Product Portfolio Delivers Strong Quarterly Performance 14 Shire's New Product Portfolio Delivers Strong Quarterly Performance 15 Shire's New Product Portfolio Delivers Strong Quarterly Performance 16 Shire's New Product Portfolio Delivers Strong Quarterly Performance 17 Shire's New Product Portfolio Delivers Strong Quarterly Performance 18 Shire's New Product Portfolio Delivers Strong Quarterly Performance 19 Shire's New Product Portfolio Delivers Strong Quarterly Performance 20 Shire's New Product Portfolio Delivers Strong Quarterly Performance 21 Shire's New Product Portfolio Delivers Strong Quarterly Performance 22 Shire's New Product Portfolio Delivers Strong Quarterly Performance 23 Shire's New Product Portfolio Delivers Strong Quarterly Performance 24 Shire's New Product Portfolio Delivers Strong Quarterly Performance 25 Shire's New Product Portfolio Delivers Strong Quarterly Performance 26 Shire's New Product Portfolio Delivers Strong Quarterly Performance 27 Shire's New Product Portfolio Delivers Strong Quarterly Performance 28 Shire's New Product Portfolio Delivers Strong Quarterly Performance 29 Shire's New Product Portfolio Delivers Strong Quarterly Performance 30 Shire's New Product Portfolio Delivers Strong Quarterly Performance 31 Shire's New Product Portfolio Delivers Strong Quarterly Performance 32 Shire's New Product Portfolio Delivers Strong Quarterly Performance 33 Rosetta Genomics to Present at Oppenheimer's 19th Annual Healthcare Conference 2 Rosetta Genomics to Present at Oppenheimer's 19th Annual Healthcare Conference 3 Sinovac to Participate in Two Upcoming Investor Conferences 2

Shire's New Product Portfolio Delivers Strong Quarterly Performance Rosetta Genomics to Present at Oppenheimer's 19th Annual Healthcare Conference Sinovac to Participate in Two Upcoming Investor Conferences

Biology Products:

Rabbit anti-UBAP2L/NICE4 AbVantage Pack Polyclonal Antibody, Unconjugated from Bethyl Laboratories Total Protein Western Blots - Plant Normal Tissue, Blot I from BioChain Rabbit Complement from Pel-Freez Biologicals Vybrant Apoptosis Assay Kit #4 from Molecular Probes (Invitrogen)